NO910473L - Fremgangsmaate for fremstilling av tricykliske aminer. - Google Patents

Fremgangsmaate for fremstilling av tricykliske aminer.

Info

Publication number
NO910473L
NO910473L NO91910473A NO910473A NO910473L NO 910473 L NO910473 L NO 910473L NO 91910473 A NO91910473 A NO 91910473A NO 910473 A NO910473 A NO 910473A NO 910473 L NO910473 L NO 910473L
Authority
NO
Norway
Prior art keywords
procedure
manufacture
tricyclic amines
tricyclic
amines
Prior art date
Application number
NO91910473A
Other languages
English (en)
Other versions
NO910473D0 (no
NO177534C (no
NO177534B (no
Inventor
Yuhpyng L Chen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO910473D0 publication Critical patent/NO910473D0/no
Publication of NO910473L publication Critical patent/NO910473L/no
Publication of NO177534B publication Critical patent/NO177534B/no
Publication of NO177534C publication Critical patent/NO177534C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO910473A 1990-02-08 1991-02-07 Analogifremgangsmåte for fremstilling av terapeutisk aktive tricykliske aminer NO177534C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47692890A 1990-02-08 1990-02-08

Publications (4)

Publication Number Publication Date
NO910473D0 NO910473D0 (no) 1991-02-07
NO910473L true NO910473L (no) 1991-08-09
NO177534B NO177534B (no) 1995-06-26
NO177534C NO177534C (no) 1995-10-04

Family

ID=23893824

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910473A NO177534C (no) 1990-02-08 1991-02-07 Analogifremgangsmåte for fremstilling av terapeutisk aktive tricykliske aminer

Country Status (21)

Country Link
EP (1) EP0441517A3 (no)
JP (1) JPH07119214B2 (no)
KR (1) KR950013562B1 (no)
CN (1) CN1054600A (no)
AU (1) AU631723B2 (no)
BR (1) BR9100519A (no)
CA (1) CA2035805C (no)
CS (1) CS29991A2 (no)
DE (1) DE9101348U1 (no)
EG (1) EG19644A (no)
FI (1) FI910592L (no)
HU (1) HUT70051A (no)
IE (1) IE910402A1 (no)
IL (1) IL97140A (no)
NO (1) NO177534C (no)
NZ (1) NZ237040A (no)
PL (2) PL167078B1 (no)
PT (1) PT96681A (no)
TW (1) TW197442B (no)
YU (1) YU21391A (no)
ZA (1) ZA91916B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
TW263504B (no) * 1991-10-03 1995-11-21 Pfizer
TW248556B (no) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
EP1891954A3 (en) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
MXPA05004715A (es) 2002-10-30 2005-08-03 Merck Frosst Canada Inc Derivados de piridopirrolizina y piridoindolizina.
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
RS62796B1 (sr) * 2017-09-07 2022-02-28 Eisai R&D Man Co Ltd Pentaciklično jedinjenje
CA3129764A1 (en) 2019-03-05 2020-09-10 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof
JOP20210219A1 (ar) 2019-03-05 2023-01-30 Eisai Randd Man Co Ltd مركب حلقات غير متجانسة خماسية الحلقات

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910947A (en) * 1969-07-24 1975-10-07 Sandoz Ag Preparation of imidazo{8 2,1-a{9 isoindoles
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
BR9100519A (pt) 1991-10-29
YU21391A (sh) 1994-01-20
NZ237040A (en) 1993-10-26
PL288977A1 (en) 1992-01-13
NO910473D0 (no) 1991-02-07
FI910592A0 (fi) 1991-02-07
CA2035805C (en) 1995-06-27
KR950013562B1 (ko) 1995-11-09
EP0441517A2 (en) 1991-08-14
TW197442B (no) 1993-01-01
JPH07119214B2 (ja) 1995-12-20
CN1054600A (zh) 1991-09-18
EP0441517A3 (en) 1992-08-19
PL166757B1 (pl) 1995-06-30
AU7087991A (en) 1991-08-29
AU631723B2 (en) 1992-12-03
DE9101348U1 (de) 1991-06-06
FI910592A7 (fi) 1991-08-09
EG19644A (en) 1995-08-30
IE910402A1 (en) 1991-08-14
CS29991A2 (en) 1991-09-15
KR910015580A (ko) 1991-09-30
ZA91916B (en) 1992-09-30
NO177534C (no) 1995-10-04
HU910406D0 (en) 1991-08-28
FI910592L (fi) 1991-08-09
HUT70051A (en) 1995-09-28
NO177534B (no) 1995-06-26
IL97140A (en) 1995-07-31
PT96681A (pt) 1991-10-31
IL97140A0 (en) 1992-05-25
JPH04234845A (ja) 1992-08-24
PL167078B1 (pl) 1995-07-31

Similar Documents

Publication Publication Date Title
FI931370L (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
FI924049L (fi) Foerfarande foer att saerskilja nukleinsyror med hjaelp av nukleotiddifferenser
NO921777D0 (no) Fremgangsmaate for fremstilling av isoparaffiner
NO912051D0 (no) Fremgangsmaate for fremstilling av azolderivater.
FI931068A7 (fi) Foerfarande foer koppling av nukleosider med en siloxanbrygga
FI931491L (fi) Foerfarande foer behandling av bomullshaltiga vaevnader med cellulas
FI923749A7 (fi) Foerfarande foer framstaellning av livsmedel med laog fetthalt
NO912848L (no) Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.
NO912346D0 (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO912808D0 (no) Framgangsmaate for framstilling av silisium-metall.
NO911122D0 (no) Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler.
NO912242L (no) Sorpsjon av trialkylarsiner.
NO910473L (no) Fremgangsmaate for fremstilling av tricykliske aminer.
NO910608D0 (no) Fremgangsmaate for fremstilling av tricykliske leukotrien-antagonister.
FI925224L (fi) Inklusionfoereningar av nimesulid med cyklodextriner
NO890483L (no) Framgangsmaate for tilvirkning av formlegemer.
FI930627A7 (fi) Modulering av celladhesion med oligonukliotider
FI925083A7 (fi) Foerfarande foer belaeggning av transplantatytor med daeggdjurceller
FI900688A0 (fi) Anordning foer luftning av liggunderlag i sjuksaeng.
NO902410D0 (no) Fremgangsmaate for rekondisjonering av stoeperisand.
NO901321D0 (no) Fremgangsmaate for fremstilling av polycykliske aminer.
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
FI924743L (fi) Foerfarande foer framstaellning av lignolytiska enzymer med phanerochaetechrysosporium
FI900273A0 (fi) Anordning foer utfaellning av fibermassa.
NO914563D0 (no) Fremgangsmaate for fremstilling av 3h-puriner